NasdaqCM - Nasdaq Real Time Price USD
Cadrenal Therapeutics, Inc. (CVKD)
16.92
+0.04
+(0.24%)
As of 1:27:00 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
Operating Cash Flow
-7,357.55
-7,357.55
-3,530.32
Investing Cash Flow
-6.54
-6.54
-3.25
Financing Cash Flow
8,979.53
8,979.53
11,903.49
End Cash Position
10,017.94
10,017.94
8,402.50
Capital Expenditure
-6.54
-6.54
-3.25
Issuance of Capital Stock
5,143.59
5,143.59
11,903.49
Repayment of Debt
--
--
-250
Free Cash Flow
-7,364.09
-7,364.09
-3,533.58
12/31/2023 - 1/20/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MAZE Maze Therapeutics, Inc.
8.73
-8.64%
IKT Inhibikase Therapeutics, Inc.
2.1650
+0.23%
SCPX Scorpius Holdings, Inc.
0.0680
-48.48%
CDIO Cardio Diagnostics Holdings, Inc.
0.4950
+8.24%
SLNO Soleno Therapeutics, Inc.
72.23
-0.06%
1BT.F Enlivex Therapeutics Ltd.
0.7950
+1.92%
ACIU AC Immune SA
1.6500
+4.43%
ENLV.TA Enlivex Therapeutics Ltd.
337.50
+2.09%
CRVS Corvus Pharmaceuticals, Inc.
3.6850
+4.69%
ARTH Arch Therapeutics, Inc.
0.1608
0.00%